Published in Clin Infect Dis on October 22, 2014
Paving the way for predictive diagnostics and personalized treatment of invasive aspergillosis. Front Microbiol (2015) 0.81
Detection of Airway Colonization by Aspergillus fumigatus by Use of Electronic Nose Technology in Patients with Cystic Fibrosis. J Clin Microbiol (2015) 0.76
Recent developments in the management of invasive fungal infections in patients with oncohematological diseases. Ther Adv Hematol (2016) 0.75
Updated practice guidelines for the diagnosis and management of aspergillosis: challenges and opportunities. J Thorac Dis (2016) 0.75
The microbiome-metabolome crosstalk in the pathogenesis of respiratory fungal diseases. Virulence (2016) 0.75
The genetics of Aspergillus nidulans. Adv Genet (1953) 18.50
Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis (2001) 6.32
Likelihood ratios with confidence: sample size estimation for diagnostic test studies. J Clin Epidemiol (1991) 5.65
Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis (2010) 5.53
Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clin Infect Dis (2006) 5.27
Fungal secondary metabolism - from biochemistry to genomics. Nat Rev Microbiol (2005) 5.27
Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis (2010) 4.98
The function of terpene natural products in the natural world. Nat Chem Biol (2007) 4.54
Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign. Clin Infect Dis (2006) 4.42
Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. Clin Infect Dis (2009) 4.19
Aspergillosis. N Engl J Med (2009) 4.11
Signal in noise: evaluating reported reproducibility of serum proteomic tests for ovarian cancer. J Natl Cancer Inst (2005) 3.31
Laboratory diagnosis of invasive aspergillosis. Lancet Infect Dis (2005) 3.31
Aspergillus infections in transplant recipients. Clin Microbiol Rev (2005) 2.82
Regulation of fungal secondary metabolism. Nat Rev Microbiol (2012) 2.45
The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis. Clin Infect Dis (2001) 2.25
Sub-telomere directed gene expression during initiation of invasive aspergillosis. PLoS Pathog (2008) 2.09
Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis. Lancet Infect Dis (2009) 2.00
Diagnostic performance of the (1-->3)-beta-D-glucan assay for invasive fungal disease. Clin Infect Dis (2009) 1.70
Patterns of susceptibility of Aspergillus isolates recovered from patients enrolled in the Transplant-Associated Infection Surveillance Network. J Clin Microbiol (2009) 1.68
Molecular identification of Aspergillus species collected for the Transplant-Associated Infection Surveillance Network. J Clin Microbiol (2009) 1.67
Metabolomics of Aspergillus fumigatus. Med Mycol (2008) 1.36
Chemistry. Roots of biosynthetic diversity. Science (2007) 1.07
Investigation into the production of 2-Pentylfuran by Aspergillus fumigatus and other respiratory pathogens in vitro and human breath samples. Med Mycol (2008) 1.06
Detection of characteristic metabolites of Aspergillus fumigatus and Candida species using ion mobility spectrometry-metabolic profiling by volatile organic compounds. Mycoses (2011) 1.04
The fumagillin biosynthetic gene cluster in Aspergillus fumigatus encodes a cryptic terpene cyclase involved in the formation of β-trans-bergamotene. J Am Chem Soc (2013) 1.02
Detection of microbial volatile organic compounds (MVOCs) produced by moulds on various materials. Int J Hyg Environ Health (2001) 0.90
Invasive fungal disease in patients treated for newly diagnosed acute leukemia. Am J Hematol (2010) 0.90
The volatome of Aspergillus fumigatus. Eukaryot Cell (2014) 0.90
Novel diagnostics: progress toward a breath test for invasive Aspergillus fumigatus. Med Mycol (2010) 0.90
Aspergillus DNA contamination in blood collection tubes. Diagn Microbiol Infect Dis (2010) 0.90
Clinical application of volatile organic compound analysis for detecting infectious diseases. Clin Microbiol Rev (2013) 0.89
Volatile disease biomarkers in breath: a critique. Curr Pharm Biotechnol (2011) 0.87
Determination of unique microbial volatile organic compounds produced by five Aspergillus species commonly found in problem buildings. AIHA J (Fairfax, Va) (2002) 0.84
Biomedically important pathogenic fungi detection with volatile biomarkers. J Breath Res (2012) 0.82